ScienceChina targets global forefront with 25% of first-in-class drugs by 2030

China’s new five-year plan for biomedicine aims to make the country a global powerhouse by 2030, with breakthroughs in key technologies and at least a quarter of the world’s first-in-class drugs market. Authorities say China will firmly rank among the global leaders in biopharmaceutical research, development and applications by the end of the decade.

Chinabiomedicinefirst-in-class drugsfive-year plan

SSouth China Morning Post★★★☆☆2026-09-18 08:00Original